SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19221131
Source:
http://linkedlifedata.com/resource/pubmed/id/19221131
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0018787
,
umls-concept:C0851827
,
umls-concept:C1280500
,
umls-concept:C1318700
,
umls-concept:C1701901
pubmed:issue
1
pubmed:dateCreated
2009-3-10
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19221131-19131365
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0077427
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cyclic GMP
,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclic Nucleotide...
,
http://linkedlifedata.com/resource/pubmed/chemical/Extracellular Matrix Proteins
,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphodiesterase 5 Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphodiesterase Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Piperazines
,
http://linkedlifedata.com/resource/pubmed/chemical/Purines
,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfones
,
http://linkedlifedata.com/resource/pubmed/chemical/sildenafil
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1755-3245
pubmed:author
pubmed-author:KuhnMichaelaM
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
82
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4-6
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:19221131-Administration, Oral
,
pubmed-meshheading:19221131-Animals
,
pubmed-meshheading:19221131-Cyclic GMP
,
pubmed-meshheading:19221131-Cyclic Nucleotide Phosphodiesterases, Type 5
,
pubmed-meshheading:19221131-Extracellular Matrix Proteins
,
pubmed-meshheading:19221131-Fibrosis
,
pubmed-meshheading:19221131-Hemodynamics
,
pubmed-meshheading:19221131-Humans
,
pubmed-meshheading:19221131-Hypertension, Pulmonary
,
pubmed-meshheading:19221131-Hypertrophy, Right Ventricular
,
pubmed-meshheading:19221131-Myocardium
,
pubmed-meshheading:19221131-Phosphodiesterase 5 Inhibitors
,
pubmed-meshheading:19221131-Phosphodiesterase Inhibitors
,
pubmed-meshheading:19221131-Piperazines
,
pubmed-meshheading:19221131-Purines
,
pubmed-meshheading:19221131-Rats
,
pubmed-meshheading:19221131-Sulfones
,
pubmed-meshheading:19221131-Ventricular Remodeling
pubmed:year
2009
pubmed:articleTitle
Cardiac anti-remodelling effects of phosphodiesterase type 5 inhibitors: afterload-(in)dependent?
pubmed:publicationType
Editorial
,
Comment